Why MedTech Companies Are Turning to Argentina: Insights from Arazy Group’s LATAM Regulatory Expert
As emerging markets open their doors to innovative healthcare technologies, Argentina is quickly becoming a top destination for MedTech expansion. In this post, we speak with Matias, Arazy Group’s Corporate Sales Manager and General Manager of the Argentine office, who shares what MedTech companies need to know about navigating regulatory access, choosing the right strategy, and moving faster into Latin America (LATAM) markets.
What Keeps You Motivated After 15 Years in MedTech Regulatory Affairs?
“I’m motivated by the impact,” says Matias. “We’re helping companies bring life-changing medical technologies to the people who need them most.”
Having worked in MedTech regulatory compliance for over a decade, Matias thrives on the global diversity of the work: new clients, evolving markets, and fast-moving regulatory challenges across multiple jurisdictions.
How Has Your Role Evolved at Arazy Group?
Matias began his journey focused on regulatory submissions and product approvals, but now supports companies more strategically.
“What MedTech companies need most is clarity. They’re not just looking for advice—they want actionable steps, a clear path, and someone who will help them complete it. That’s what we do best at Arazy Group.”
Why is Argentina a Strategic Market for MedTech Companies in 2025?
Argentina is experiencing a regulatory transformation, aligning more closely with MERCOSUR standards and creating a smoother pathway for foreign medical device manufacturers. According to Matias, this, combined with rising demand for digital health, diagnostics, and SaMD (Software as a Medical Device), makes Argentina one of the most strategic MedTech markets in Latin America.
What Types of MedTech Products Succeed in Argentina?
MedTech companies offering the following technologies are well-positioned:
- Digital health platforms and diagnostics
- Connected and portable medical devices
- Cost-effective technologies requiring minimal hospital infrastructure
“Argentina values practical innovation,” Matias explains. “Solutions that are scalable, easy to implement, and don’t rely on large-scale infrastructure are a strong fit for this market.”
Top Concerns from MedTech Companies Entering LATAM
From long approval timelines to uncertainty about local requirements, many MedTech firms express hesitation about expanding into LATAM.
Matias emphasizes that Arazy Group’s model is designed to address these challenges directly.
“Unlike most firms, we tie our compensation to successful submissions, not hourly billing. We take ownership of the process and outcome, which builds trust and reduces client risk.”
Arazy Group also offers bundled regulatory services, including clinical evaluation, cybersecurity validation, labelling, and QMS generation, especially valuable for SaMD companies seeking a turnkey regulatory solution.
6. Final Advice for MedTech Leaders Considering Expansion
“Don’t wait until everyone else is there,” Matias advises. “Early movers in emerging markets often gain the most, but only when they enter with the right plan and partner.”
Arazy Group helps streamline regulatory approval, reduce friction, and deliver clear guidance in complex markets like Argentina, Brazil, and across LATAM.
With over 15 years of experience in global MedTech regulatory strategy, Matias leads Arazy Group’s LATAM expansion efforts. Outside of work, he enjoys padel, woodworking, and exploring city mornings. He’s passionate about building lasting client relationships and simplifying complex regulatory pathways.
Ready to expand your MedTech product into Argentina or other LATAM markets?
Let Arazy Group guide your regulatory success. Contact us today to get started.
